Project Summary
When this study is complete, Dr. Chavali’s team will be able to provide novel molecular tools and pathways which will provide information to better understand what causes AMD. For the very first time, understanding the role and function of long non-coding RNA (lncRNAs) which are associated with AMD might lead to the development of novel therapeutic agents that target these pathways. Despite the increasing interest in the study of lncRNAs in a host of biological processes and diseases, this is the first research proposed to identify and characterize the relation of lncRNAs with AMD. Dr. Chavali’s study will characterize the differentially expressed (DE) lncRNAs in AMD which may lead to the development of new biomarkers and therapy.
When this study is complete, Dr. Chavali’s team will be able to provide novel molecular tools and pathways which will provide information to better understand what causes AMD. For the very first time, understanding the role and function of long non-coding RNA (lncRNAs) which are associated with AMD might lead to the development of novel therapeutic agents that target these pathways. Despite the increasing interest in the study of lncRNAs in a host of biological processes and diseases, this is the first research proposed to identify and characterize the relation of lncRNAs with AMD. Dr. Chavali’s study will characterize the differentially expressed (DE) lncRNAs in AMD which may lead to the development of new biomarkers and therapy.
This study will use eye tissues from eyes generously donated for medical research to the Alabama Eye Bank, which were collected using funds from Arnold and Mabel Beckman Institute of Macular Research (BIMR) grant to Drs. Christine A. Curcio and Dwight Stambolian. The first aim of Dr. Chavali’s study involves analyzing the sequence of the transcriptome isolated from normal and AMD donor eyes, to reveal the DE lncRNAs and mRNAs in the retina and RPE/choroid tissues. This will be the first time that anyone has attempted to study the role of non-coding elements in the eye and understand if they play a role in causing AMD.
In the second aim, Dr. Chavali’s team intends to characterize the function of these DE lncRNAs to understand their association with AMD. The sequences of the lncRNAs obtained above will be analyzed by aligning against the total human genome (hg19) database. The team will use publically-available bioinformatics software and a home-brewed bioinformatics computer analysis pipeline to annotate the DE lncRNA/mRNA into gene expression clusters. Methods will be used to understand the role of the DE lncRNAs in a number of pathways that are important for normal function and maintenance of the retina and RPE/choroid.
In the team’s third aim, they propose to functionally characterize five DE lncRNA that have a significantly altered expression in AMD. They propose to study where the DE lncRNA are located, both overexpress and completely diminish their expressions, and analyze their function both in vitro (cell line cultures) and in vivo (animals/tissues) to study and understand how lncRNAs potentially influence the development of AMD.
Better understanding how the differential regulation of lncRNAs influence AMD might help to alter the way treatments are managed and/or delay the onset of AMD, leading to an improved quality of life for the elderly. Dr. Chavali’s team is extremely excited to study the role of these lncRNAs in causing AMD, and cannot sufficiently express their gratitude to those willing to support this work.
